Position in SPRY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,397,999
+$147,850 QoQ
Shares Held
549,064
+3.7% QoQ
Ownership
0.552%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 209 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in SPRY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. SPRY ranks #174 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in SPRY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,397,999 | 549,064 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $4,250,149 | 529,284 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $6,069,752 | 521,009 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $5,341,603 | 531,503 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $8,463,493 | 485,014 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $6,126,999 | 487,043 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,044,513 | 478,153 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $6,559,509 | 452,380 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,277,028 | 267,571 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,678,752 | 262,109 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,423,051 | 259,681 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $987,109 | 261,140 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,545,629 | 230,691 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $468,524 | 71,970 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $574,094 | 67,303 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $207,418 | 39,284 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $157,982 | 37,260 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $609,227 | 173,569 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,197,853 | 179,858 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,853,754 | 185,747 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,888,987 | 125,898 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,871,898 | 134,584 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||